Galor A - Search Results

1

A Comparative Study of Central Corneal Epithelial, Stromal, and Total Thickness in Males With and Without Primary Open-Angle Glaucoma.

Batawi H, Lollett IV, Maliakal C, Wellik SR, Anderson MG, Feuer W, Karp CL, Galor A. Batawi H, et al. Among authors: galor a. Cornea. 2018 Jun;37(6):712-719. doi: 10.1097/ICO.0000000000001575. Cornea. 2018. PMID: 29553989 Free PMC article.

2

Femtosecond-assisted anterior lamellar corneal staining-tattooing in a blind eye with leukocoria.

Kymionis GD, Ide T, Galor A, Yoo SH. Kymionis GD, et al. Among authors: galor a. Cornea. 2009 Feb;28(2):211-3. doi: 10.1097/ICO.0b013e3181859fbb. Cornea. 2009. PMID: 19158567

3

Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.

Galor A, Karp CL, Chhabra S, Barnes S, Alfonso EC. Galor A, et al. Br J Ophthalmol. 2010 May;94(5):551-4. doi: 10.1136/bjo.2008.153197. Epub 2009 Jun 2. Br J Ophthalmol. 2010. PMID: 19493859

4

Recurrence rates of herpes simplex virus keratitis in contact lens and non-contact lens wearers.

Mucci JJ, Utz VM, Galor A, Feuer W, Jeng BH. Mucci JJ, et al. Among authors: galor a. Eye Contact Lens. 2009 Jul;35(4):185-7. doi: 10.1097/ICL.0b013e3181a9d788. Eye Contact Lens. 2009. PMID: 19502988

5

Subconjunctival mycetoma after sub-Tenon's corticosteroid injection.

Galor A, Karp CL, Forster RK, Dubovy SR, Gaunt ML, Miller D. Galor A, et al. Cornea. 2009 Sep;28(8):933-5. doi: 10.1097/ICO.0b013e3181930bb7. Cornea. 2009. PMID: 19654518

6

Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye.

Galor A, Davis JL, Flynn HW Jr, Feuer WJ, Dubovy SR, Setlur V, Kesen MR, Goldstein DA, Tessler HH, Ganelis IB, Jabs DA, Thorne JE. Galor A, et al. Am J Ophthalmol. 2009 Nov;148(5):704-710.e2. doi: 10.1016/j.ajo.2009.05.033. Epub 2009 Aug 7. Am J Ophthalmol. 2009. PMID: 19665105

7

Adverse effects of smoking on patients with ocular inflammation.

Galor A, Feuer W, Kempen JH, Kaçmaz RO, Liesegang TL, Suhler EB, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Thorne JE. Galor A, et al. Br J Ophthalmol. 2010 Jul;94(7):848-53. doi: 10.1136/bjo.2009.174466. Br J Ophthalmol. 2010. PMID: 20606023 Free PMC article.

8

Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.

Karp CL, Galor A, Chhabra S, Barnes SD, Alfonso EC. Karp CL, et al. Among authors: galor a. Ophthalmology. 2010 Dec;117(12):2241-6. doi: 10.1016/j.ophtha.2010.03.052. Ophthalmology. 2010. PMID: 20619462

9

Pegylated interferon alpha 2b for treatment of ocular surface squamous neoplasia: a pilot study.

Karp CL, Galor A, Lee Y, Yoo SH. Karp CL, et al. Among authors: galor a. Ocul Immunol Inflamm. 2010 Aug;18(4):254-60. doi: 10.3109/09273948.2010.486687. Ocul Immunol Inflamm. 2010. PMID: 20662655

10

Subconjunctival masses associated with central nervous system rosai-dorfman disease.

Cavuoto K, Galor A, Dubovy SR, Gregori N, McCarthy M. Cavuoto K, et al. Among authors: galor a. Cornea. 2011 Feb;30(2):237-40. doi: 10.1097/ICO.0b013e3181e4570c. Cornea. 2011. PMID: 20847659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

398 results

Search Page